Drugs / recombinant human somatotropin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00497484 | — | pituitary dwarfism, pseudohypoparathyroidism type 1A | University of Milan | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant human somatotropin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00497484 ↗ |
| Known as | rhGH | “CONTEXT: Since the identification of GH deficiency due to resistance to GHRH in patients with pseudohypoparathyroidism type Ia (PHP-Ia), no study investigated the effects of...” PMID 20719837 ↗ Aug 2010 |
| Modality | Protein / enzyme biologic | “recombinant human GH (rhGH) therapy” PMID 20719837 ↗ Aug 2010 |